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ABSTRACT: 
Introduction: Pharmacists in the UK can register as Independent Pharmacist Prescribers 
(IPPs) upon completion of appropriate Higher Education training. IPPs have had the same 
prescribing privileges as medical doctors since 2009. Despite the years since their 
introduction, there is little data available to demonstrate the frequency and type of errors 
made by IPPs. Furthermore, there is no literature available comparing IPPs to doctors with 
regards to prescribing safety. This study aimed to start to fill this gap in the literature. 
Methods: Pharmacists working in one NHS Trust, in areas with a large proportion of 
prescribing undertaken by IPPs, were purposefully recruited to collect data over a one week 
period in May 2018. They collected data on all prescription items validated that were 
prescribed by IPPs and doctors. Errors that were identified were recorded in detail. Data 
collection forms and error definitions were taken from the EQUIP study, a large study 
looking at prescribing errors by junior doctors in the hospital setting. 
Results: 5840 prescriptions items were recorded; 1026 (17.6%) were prescribed by an IPP. 
479 errors were recorded in total. Experienced IPPs, had a 1% error rate (7 errors); IPPs with 
less experience had a 0% error rate. Overall the error rate for pharmacists was 0.7% (95% CI 
0.0-1.0). In comparison, doctors made an average of 9.8% errors (95% CI 9.0-11.0). 
Pharmacists made significantly less prescribing errors than doctors (p<0.01). 85.7% of IPP 
errors were recorded as minor in significance, compared to an average of 31.7% for all 
ĚŽĐƚŽƌ ?ƐƉƌĞƐĐƌŝďŝŶŐĞƌƌŽƌƐ ?ĐƚƵĂůƉĂƚŝĞŶƚŚĂƌŵŽĐĐƵƌƌĞĚĨƌŽŵ ? ? ? ?A?ŽĨĂůůƉƌĞƐĐƌŝƉƚŝŽŶƐ ? 
Conclusion: In a single NHS Trust, pharmacists make significantly less prescribing errors than 
doctors. Embedding IPPs with more integrated roles in the multi-disciplinary team is 
recommended. Further large trials are required to validate the results of this study. 
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Keywords: Clinical Pharmacy, Electronic Prescribing, Medical Errors, Risk Management, 
Clinical Audit, Competency Evaluation 
Key Messages: 
What is already known on this subject: 
x The error rate for Independent Pharmacist Prescribers (IPP) is documented to be 
between 0-1.2% from small observational studies. 
x dŚĞĞƌƌŽƌƌĂƚĞƐĨŽƌĚŽĐƚŽƌƐ ?ƉƌĞƐĐƌŝďŝŶŐŝƐĚŽĐƵŵĞŶƚĞĚƚŽďĞ ? ? ?A?ĨƌŽŵĂůĂƌŐĞŵƵůƚŝ-
centre study.  
x dŚĞƌĞŝƐŶŽůŝƚĞƌĂƚƵƌĞƚŚĂƚĚŝƌĞĐƚůǇĐŽŵƉĂƌĞƐ/WWĂŶĚĚŽĐƚŽƌƐ ?ƉƌĞƐĐƌŝďŝŶŐĞƌƌŽƌƐŝŶ
terms of frequency or types of errors. 
What this study adds: 
x This study provides the first set of data demonstrating that IPPs have a significantly 
lower prescribing error rate than doctors. 
x This study provides a starting point for future research to support the increased 
utilisation of pharmacist prescribers in the multi-disciplinary team in the hospital 
setting. 
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INTRODUCTION 
Pharmacists, who have been on the professional register for more than two years and who 
have successfully completed an accredited course at a Higher Education Institute, have been 
able to act as supplementary prescribers (prescribing within a clinical management plan 
ĂŐƌĞĞĚǁŝƚŚƚŚĞƉĂƚŝĞŶƚ ?ƐĚŽĐƚŽƌ ? since 2003. 1 Further legislative changes in 20062, 20093 
and 20124 resulted in pharmacists prescribing independently with the same prescribing 
powers as doctors.  
 
Rational prescribing is a complex process; the healthcare professional must generate or 
confirm a diagnosis and select a suitable therapy, being mindful of the relative 
appropriateness of the intervention for that patient5. Like any complex processes, there is 
potential for error at various points.  ůĞĂƌůǇĚĞĨŝŶŝŶŐĂ ?ƉƌĞƐĐƌŝďŝŶŐĞƌƌŽƌ ?ŝƐĚŝĨĨŝĐƵůƚĂƐƚŚĞ
ƚĞƌŵƐ ?ŵĞĚŝĐĂƚŝŽŶĞƌƌŽƌƐ ?ĂŶĚ ?ƉƌĞƐĐƌŝďŝŶŐĞƌƌŽƌƐ ?ĂƌĞŽĨƚ ŶƵƐĞĚŝŶƚĞƌĐŚĂŶŐĞĂďůǇ ?For the 
purposes of this study:  ?ĐůŝŶŝĐĂůůǇŵĞĂŶŝŶŐĨƵůƉƌĞƐĐƌŝďŝŶŐĞƌƌŽƌŽĐĐƵƌƐǁŚĞŶ ?ĂƐĂƌĞƐƵůƚŽĨ
a prescribing decision or prescription writing process, there is an unintentional significant 
(1) reduction in the probability of treatment being timely and effective or (2) increase in the 
ƌŝƐŬŽĨŚĂƌŵǁŚĞŶĐŽŵƉĂƌĞĚǁŝƚŚŐĞŶĞƌĂůůǇĂĐĐĞƉƚĞĚƉƌĂĐƚŝĐĞ ?.6 
 
An observational study by Baqir et al examined the prevalence of prescribing error rates for 
IPPs within a UK hospital. Of the 1415 prescription items reviewed, they found a 0.3% error 
rate amongst IPP prescriptions.7 Three other studies report the IPP prescribing error rate to 
be from 0% to 1.2%8,9,10, although these three studies did not focus exclusively on errors. 
The EQUIP study investigated doctors ? prescribing errors across 19 hospitals and found an 
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average of 8.9% errors amongst doctors ? prescription items. This study also recorded IPP 
prescriptions however only 179 items were prescribed by pharmacists with a 0% error rate. 
There is no literature that directly compares IPP and doctors prescribing errors in terms of 
frequency or types of errors.11 
 
The aim of this research was to determine if there is a statistically significant difference in 
error rates between IPP prescriptions and ĚŽĐƚŽƌƐ ?prescriptions. Secondary aims were to 
determine the types of errors made by IPPs and whether experience affects the frequency 
and types of errors. 
METHODS 
 
Data were collected from prescription items for adult inpatients across medical and surgical 
wards at one large acute hospital Trust in England throughout May 2018; the time 
restriction determined the sample size. Pharmacists (IPPs and non-prescribing pharmacists) 
working across a range of specialties and wards volunteered and were trained to collect 
data. This convenience sampling approach to data collection allowed us access to a much 
larger data set than using random sampling with potentially lower numbers of data 
collectors. Haematology, oncology and paediatric wards were excluded from data collection.  
 
Pharmacist and doctors were grouped according to the grading of their job roles. In England, 
IPP Foundation Pharmacists (FP) have two years post-qualification experience, band 7 
pharmacists have > two ǇĞĂƌƐ ?ĞǆƉĞƌŝĞŶĐĞ and band 8a and above the most experience or 
level of seniority. Foundation Year 1 (FY1) doctors are newly qualified and for doctors have 
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the least prescribing experience followed by FY2, core trainees, registrars and consultants 
being the most experienced. Data collection included details regarding the grading of the 
prescriber to allow us to determine if experience level affects the frequency of prescribing 
errors. 
 
Classification of prescribing errors is usually undertaken by defining the type of error and/ or 
the severity of the error. This study recorded both the type and the severity of all errors 
documented. The classification of errors was reviewed by the lead author and one other 
experienced pharmacist to ensure correct classification and identification of errors.  
 
The   ?ĞƌƌŽƌƚǇƉĞ ?ĚĞĨŝŶŝƚŝŽŶƐ used in this study (table 1)  were used in the EQUIP study.11 
Following a pilot of the data collection form, it was identified that two types of errors were 
not well described by the classification; incorrect choice of antibiotic and incorrect dosage 
due to renal function. Therefore these types of errors were added to the classification in the 
EQUIP study.10 
Table 1: Error Types 
  
Omission on admission Drug not prescribed but indicated 
Underdose Continuation for longer than needed 
Overdose Route missing 
Strength/dose missing Start date incorrect/missing 
Omission on discharge prescription Controlled Drug requirements 
incorrect/missing 
Administration times incorrect/missing Drug interaction 
Duplication Daily dose divided incorrectly 
Product/formulation not specified Significant allergy 
Incorrect formulation Continuation after adverse drug 
reaction 
No maximum dose Premature discontinuation 
Unintentional prescription of drug Drug interaction not taken into account 
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No signature No dosage alteration after levels out of 
range 
Clinical contra-indication Dose/rate mismatch 
Incorrect drug or dosage for renal function Incorrect choice of antibiotic 
Incorrect route Drug not prescribed but indicated 
No indication Continuation for longer than needed 
Intravenous administration instructions 
incorrect/missing 
Route missing 
 
The severity classification of errors was also taken from the EQUIP study11 which categorises 
ĞƌƌŽƌƐĂƐ ?ŵŝŶŽƌ ? ? ?ƐŝŐŶŝĨŝĐĂŶƚ ? ? ?ƐĞƌŝŽƵƐ ?ĂŶĚ ?ƉŽƚĞŶƚŝĂůůǇůĞ ŚĂů ? (table 2).  
 
All data were reviewed by the authors to ensure it was accurately classified and unbiased. 
Data were analysed by descriptive statistical analysis using SPSS.
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Table 2: Assessing severity of prescribing errors 
 
Error classification Error description 
Potentially lethal error 
An error is defined as potentially lethal if it could have one or more of the following consequences:    
The serum level resulting from such a dose is likely to be in the severe toxicity range based on common dosage guidelines, e.g. serum theophylline concentrations 
greater than 30 micrograms per ml.  
More than 10 times the dose of chemotherapy agent  
The drug being administered has a high potential to cause cardiopulmonary arrest in the dose ordered. 
The drug being administered has a high potential to cause a life threatening adverse reaction, such as anaphylaxis, in light RIWKHSDWLHQW¶VPHGLFDOKLVWRry.  
The dose of a potentially lifesaving drug is too low for a patient having the disease being treated  
 The dose of a drug with a very low therapeutic index is too high (ten times the normal dose) 
Serious error 
An error is defined as serious if it could have one or more of the following results:  
The route of drug administration ordered is inappropriate, with the potential of causing the patient to suffer a severe toxic reaction.  
The dose of the drug prescribed is too low for a patient with serious disease who is in acute distress 
The dose of a drug with a low therapeutic index is too high (four to ten times the normal dose) 
The dose of the drug would result in serum drug levels in the toxic range, e.g. theophylline levels 20-30 micrograms per mL. 
7KHGUXJRUGHUVFRXOGH[DFHUEDWHWKHSDWLHQW¶VFRQGLWLRQHJGUXJ-drug interaction or drug-disease interaction and a clear clinical consideration has not been 
documented. 
The name of the drug is misspelled or illegible creating a risk that the wrong drug might be dispensed including errors in decimal points or units if the error could 
lead to the dose being given 
High dosage (ten times) normal of a drug without a low therapeutic index 
An error is defined as significant if it could have one or more of the following results:   
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Significant error 
The dose of the drug with low therapeutic index is too high (half ± four times the normal dose) 
The dose of the drug is too low for a patient with the condition being treated 
The wrong laboratory studies to monitor a specific side effect of a drug are ordered e.g. CBC and reticulocyte counts are ordered to monitor gentamicin toxicity 
The wrong route of administration for the condition being treated is ordered e.g. the inadvertent change from IV to oral therapy for the treatment of bacterial 
meningitis 
Errors ordering fluids are made e.g. specific additives needed for complete therapy are omitted or incompatible fluids are ordered 
(UURUVRIRPLVVLRQZKHUHE\SDWLHQW¶VUHJXODUPHGLFDWLRQLVQRWSUHVFULEHGHLWKHURQDGPLVVLRQGXULQJDUHZULWHDQGRQGLVFKDrge 
Minor error 
An error is defined as minor if it could have one or more of the following results:  
Duplicate therapy was prescribed without potential for increased adverse effects 
The wrong route was ordered without potential for toxic reactions or therapeutic failure 
The order lacked specific drug, dose, dosage strength, frequency, route or frequency information 
Illegible, ambiguous or non-standard abbreviations 
An errant order was written that was unlikely to be carried out given the nature of the drug, dosage forms, route ordered, missing information etc 
Examples include, simvastatin prescribed in the morning rather than at night. Bisoprolol ± two puffs four times a day 
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RESULTS 
The primary outcome of this study was the frequency of prescribing errors made by IPPs 
compared to doctors. Table 3 demonstrates the number of prescriptions written in total and 
by each professional group and the % error rate for each group. The prescribing error rate 
for IPPs was 0.7% (95% CI 0.0-1.0) compared with a prescribing error rate of 9.8% (95% CI 
9.0-11.0) ĨŽƌĂůůĚŽĐƚŽƌƐ ?ƉƌĞƐĐƌŝƉƚŝŽŶƐ ?p<0.01).  Figure 1 shows the severity of errors made 
by each professional group. 
Table 3: Number of prescribed items written and prescription errors made 
by professional group 
 
  Type of prescriber Total 
Pharmacist 
8a or above 
Pharmacist 
band 7 or 
3rd year FP 
Doctor 
FY1, 
FY2,CT or 
equivalent 
Registrar Consultant Doctor 
unknown 
Total 
prescriptions 
written 
699 327 4041 464 171 138 5840 
Number of 
errors 
7 0 388 66 10 8 479 
% prescribing 
errors 
1.0% 0.0% 9.6% 14.2% 5.8% 5.8%  8.4% 
 
Registrars were the professional group contributing the largest error rate at 14.2% (95% CI 
11.0-17.0). Band 7 or 3rd year FP pharmacists contributed the smallest error rate at 0%, 
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closely followed by band 8a and above pharmacists with a 1% (95% CI 0.0-2.0) error rate. 
Box 1 describes the errors made by pharmacists. 
 
Seventy seven errors, all made by doctors, were removed from the full analysis due to lack 
of detail provided; these errors are included in the overall error frequencies. 
 
 
 
Box 1: Description of errors made by pharmacists 
Significant errors: 
1. Valganciclovir PO twice weekly  
a. Prescribed to have twice weekly - Saturday and Wednesday evening. However not 
prescribed to start until Saturday when initially prescribed Wednesday morning. 
Patient would have missed a dose if not corrected 
i. Error type: Start date incorrect/ missing 
2. Darbopoetin 
a. 30mg prescribed instead of 130mg on admission (patient already prescribed prior 
to admission).  
i. Error type: Underdose 
Minor errors: 
3. Teicoplanin IV  
a. correctly prescribed but without an indication on the chart 
i. Error type: No indication 
4. Lansoprazole 
a. Re-prescribed formulation as per admission but didn't cease incorrect prescription 
i. Error type: Duplication 
5. Fostair inhaler 
a. Re-prescribed formulation as per admission but didn't cease incorrect prescription 
i. Error type: Duplication 
6. Laxido sachets 
a. Re-prescribed dose  as per admission but didn't cease incorrect prescription 
i. Error type: Duplication 
7. Salbutamol 
a. Re-prescribed formulation as per admission but didn't cease incorrect prescription 
i. Error type: Duplication 
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DISCUSSION 
To our knowledge, this is the first study that focuses on prescribing errors and directly 
compares IPP prescribing with ĚŽĐƚŽƌƐ ? prescribing in any sector of care. It is only the second 
study that provides coverage of errors by a large group of IPPs, across a number of 
specialities. It is also only the second study with a specific focus on IPP prescribing errors. 
With an overall error rate of 0.7% for IPPs, compared to 9.8% for doctors, this study 
demonstrates that pharmacists make significantly less prescribing errors, and are therefore 
significantly safer prescribers than doctors based on this cross sectional observation. 
 
A mean prescribing error rate of 0.7% by IPPs compares favourably to other studies who 
reported a 0.18% to 1.2% error rate.7,8,9,10 
 
Band 8a IPPs with (generally) more experience than band 7 IPPs made more prescribing 
errors; band 7 IPPs made no errors from the data collected.  The sample size of band 7 IPP 
errors was smaller, limiting the power to detect a true error rate. One theory for the 
difference may be a difference in confidence level between the two groups.  
 
Complexity of medicines regimens prescribed by IPPs may be associated with their level of 
experience. From the errors made by experienced pharmacists, three were complex 
medicines (only prescribed in specialist areas or with a complex dosing or administration 
regime) whereas four were on commonly prescribed medicines. None of these were 
knowledge-based mistakes, all were slips of action or memory lapses.12 Another theory, 
better supported by the data, may be that increasing experience means completing tasks 
that the individuals are strongly familiar with and do not require full attention; they may 
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also be more likely to become distracted as they are more familiar with the task.12 System 1 
 ?ĂƵƚŽŵĂƚŝĐ ?ƚŚŝŶŬŝŶŐŽĐĐƵƌƐǁŚĞŶŽŶĞŝƐĨĂŵŝůŝĂƌǁŝƚŚĂƚ ƐŬ ?ƐǇƐƚĞŵ ?ƚŚŝŶŬŝŶŐůĞĂĚƐƚŽĂŶ
increased error rate but decreased significance of errors.13  More senior staff usually have 
increased responsibilities, including supervising and supporting junior staff; the increase in 
workload outside prescribing activities may also contribute to error rates. 
 
tŝƚŚ ? ? ? ?A?ŽĨ/WWĞƌƌŽƌƐďĞŝŶŐĐůĂƐƐĞĚĂƐ ?ŵŝŶŽƌ ? ?ƚŚĞƐĞǀĞƌŝƚǇŽĨƉŚĂƌŵĂĐŝƐƚĞƌƌŽƌƐǁĂƐĂůƐŽ
lower than those made by doctors which impacts positively on patient safety. None of the 
pharmacist prescriptions led to harm, this was comparable to other groups of prescribers 
with the exception of FY1/FY2/CT or equivalent with a harm rate of 0.05% from all 
prescriptions written by this group. Overall, the severity of errors reported for doctors was 
comparable to those described in the EQUIP study.11 Overall, the incidence of actual harm 
to patients from prescribing errors was low. This demonstrates that although the overall 
error rate was high, either these errors did not cause harm or were corrected prior to the 
drug being administered. A UK study looking at prescribing errors in hospital inpatients 
found that 57.7% of errors were rectified by a pharmacist prior to a dose being administered 
to the patient.14 The EQUIP study also found that doctors rely heavily on pharmacists and 
nurses to identify and correct prescribing errors.11 
 
Comparison of the prescribing activity of pharmacists and doctors, particularly workload 
pressures, the complexity and autonomy of the process, was not investigated as part of this 
study. It is likely to be very difficult, even with a controlled study, to investigate the effect of 
workload pressures however this could lend weight to the argument for increasing 
pharmacist prescribing to reduce workload pressures on doctors and improve safety for 
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patients. The literature, demonstrates that pharmacists are prescribing across broad areas 
including complex medicines and conditions.7,8,9,10 Experience from practice indicates that 
IPP activity is very comparable to that of junior doctors; a considerable amount of 
prescribing is undertaken with support from the multidisciplinary team (MDT). Some 
pharmacists prescribe completely autonomously; making decisions without the support of 
others, similar to consultants and senior registrars. Fully autonomous IPP prescribing may 
occur in a number of settings however those IPPs who do a majority of their prescribing 
completely autonomously usually work in pharmacist led outpatient clinics where they are 
not fully supported by the presence of a doctor; this data was not captured as part of this 
study. Further study would be required to investigate the safety of pharmacist prescribing 
while working out of hours to support increased utilisation of pharmacist prescribers to 
improve safety 24/7. 
 
There is a body of literature available evaluating the clinical effectiveness of IPPs in practice. 
This demonstrates that IPPs are as effective as doctors, or more so, at gaining positive 
clinical outcomes for patients when prescribing15,16,17,18  and views of patients on IPP 
prescribing in the literature are encouraging.19, 20 It has also been shown that IPPs involve 
the patient more in decisions about their medicines. 21 
 
In addition to the study by Baqir et al, who demonstrated that IPPs make very low numbers 
of errors,7 we can provide evidence that pharmacists are not only safe, but due to the 
significantly reduced error rate are perhaps safer than doctors. Recommendations from the 
evidence produced by this study include the wider role out of IPPs in hospital practice and 
deeper involvement in the MDT. It is suggested that the results of this study can be used to 
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support shaping the future IPP workforce; IPPs should be deployed to undertake a much 
higher proportion of prescribing in order to improve patient safety. 
 
Limitations of this study include the use of pharmacists to collect data about errors made by 
other pharmacists. Pharmacists and doctors knew that the study was being undertaken; this 
may have improved focus on prescribing accuracy via the Hawthorne effect.22 The option 
provided to data collectors of selecting the days of data collection may have led to all data 
being collected by an individual on a certain week day as it was quieter which could have 
impacted on the results. Furthermore, data were only collected on week days; data from 
weekends could show a different result. Pharmacists were prescribing in a ward-based 
setting only; data from outpatient clinics may show a different result.  
 
It should be noted that this study is observational and not controlled to directly compare 
like for like. Results are correlational and can only provide a basis for speculation as to the 
difference in error rate between professional groups which could be explored further. There 
was no consideration of the variances between the type of work undertaken by pharmacists 
and doctors, workload pressures or the influence of shift working on medical prescribing.  
 
Analysis comparing like for like in experience level was not undertaken. Prescribing 
pharmacists already have at least 2 years post-qualification experience and may be working 
permanently in a single speciality. Newly qualified doctors were included in this study; they 
move clinical areas regularly and must quickly become familiar with specialisms. The authors 
ƚƌŝĞĚƚŽŵŝƚŝŐĂƚĞĨŽƌƚŚŝƐďǇĐŽůůĞĐƚŝŶŐĚĂƚĂŽŶůǇŝŶ ?ŶŽŶ-ƐƉĞĐŝĂůŝƐƚ ?ĂƌĞĂƐŚŽǁĞǀĞƌǀĂƌŝĂŶĐĞƐ
between generalist areas will still be present; more detailed future studies may allow for 
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this. The generalisability of the findings of this study outside adult medicine and surgery, or 
outside the individual hospital Trust is also perhaps limited.
CONCLUSION 
This study demonstrates that in a single NHS Trust, IPPs working in adult medicine and 
surgery are safer prescribers than doctors. Errors made by IPPs are low in significance and 
do not lead to patient harm. This suggests that increasing prescribing activity of IPPs and 
embedding this activity into the MDT would improve patient safety around prescribing. 
Further large controlled studies are required to validate the results of this study outside the 
individual Trust and across wider areas of practice, taking in to consideration the limitations 
of this study to support future workforce development from a safety perspective.  
FIGURE LEGEND 
Figure 1: The severity of errors made by prescribers by professional group. Pharmacists 
made no serious errors and a majority of pharmacist errors were minor. Overall, pharmacist 
errors were less serious than medical prescriber errors. Only FY1/FY2/ SHO and registrars 
made any serious errors. No potentially lethal errors were made. 
 
Box 1: A description of the errors made by pharmacists broken down in to severity and error 
type. The most common pharmacist error type was duplication.  
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